u/samir_falk

It is a dual GIP and GLP-1 receptor agonist, and the GIP arm is the part that has no equivalent in the semaglutide threads. That is why the side-effect profile reads differently rather than just milder.

Have you asked the pharmacist to check?

Resolution between two peaks depends on retention, selectivity and efficiency. A shallower gradient buys retention and usually resolution, at the cost of peak width and run time.

Asked Homopeptide which lines they hold regionally before ordering and got a straight list back. Changed what I ordered and when.

Perimenopause and all of this at once, and there is essentially nothing written about the combination anywhere.

Agreed on rigid packaging. It costs the shipper almost nothing and it predicts a lot about the rest of the operation.

Have you asked a pharmacist about the absorption question specifically?

2.5mg is a four-week starting dose, not a maintenance dose. Worth being precise since people search these threads.

Which week did the appetite change actually land for you?

Disagree with the conversion table. There is no validated equivalence between the two molecules and posting one as though there is does real damage.

Agreed. The hepatic programme is the point of this compound and the weight discussion is a side effect of the side effect.

The honest evidence position, written out so this board does not drift.

Adding the standing caveat — unapproved compound, research material is not for human use.

Agreed, and the trial number is a mean of a very wide distribution — the tails are enormous and nobody posts from the middle.

Resolution between two peaks depends on retention, selectivity and efficiency. A shallower gradient buys retention and usually resolution, at the cost of peak width and run time.

fibrosis improvement without worsening steatohepatitis is the phrase to learn

Started reporting my own integrations with the baseline choice stated.

mass_spec_maggie is right — the integration choice is a decision and it should be stated alongside the result.

baseline choice is a decision, not a measurement

Yes — hair shedding tracks the rate of loss and it is temporary.

kaia_fonseca is right that a diagnosis and a finding are different things here.

Correcting myself upthread: the shedding started at week 26 for me, not the week I gave.

It is a dual GIP and GLP-1 receptor agonist, and the GIP arm is the part that has no equivalent in the semaglutide threads. That is why the side-effect profile reads differently rather than just milder.

Employer-sponsored plans have their own criteria and appeal processes, independent of the provincial formulary. Which one applies determines everything about the route.

you cannot report to two decimals off that baseline

Careful — the supplier does not control the last mile and most of your variance is in it.

Correction to my own post above — I said 15mg and I have been on 10mg since the spring. Same argument, wrong number.

Independent purity results for this compound are very sparse across the whole site, which means any impression about consistency is built on almost nothing.

The same dose genuinely feels different at different points in the month for me. Took a year to notice and it was in the log the whole time.

SURMOUNT-1 ran 72 weeks with the top arm around 21% mean body weight change. SURPASS is the diabetes programme and reports glycaemic endpoints, so quoting the two interchangeably is a category error.

Do you have the mass, or only the UV trace?

Disagree with the conversion table. There is no validated equivalence between the two molecules and posting one as though there is does real damage.

retention time alone is not identity

Push back: approval by the national regulator says nothing about whether any plan will pay.

That is area percent, not mass percent. The trace cannot give you the second one.

Which week did the appetite change actually land for you?

Correction to my own post above — I said 10mg and I have been on 5mg since the spring. Same argument, wrong number.

Is that baseline drawn by the software or by hand?

Do they publish a reship policy, and did you read it before ordering?

Resolution between two peaks depends on retention, selectivity and efficiency.

Disagreeing with this bit: that spread is ordinary inter-lab variance, not a disagreement about the material.

Yes — 10mg being a genuine landing place for a lot of people is underrated. There is no medal for 15.

a quoted lead time you can hold them to is worth more than a fast one you cannot

That figure cannot be quoted to two decimals off that baseline. The precision is not in the data.